Suppr超能文献

C反应蛋白在下呼吸道感染中的诊断价值:系统评价

Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

作者信息

van der Meer Victor, Neven Arie Knuistingh, van den Broek Peterhans J, Assendelft Willem J J

机构信息

Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC, Leiden, Netherlands.

出版信息

BMJ. 2005 Jul 2;331(7507):26. doi: 10.1136/bmj.38483.478183.EB. Epub 2005 Jun 24.

Abstract

OBJECTIVES

To evaluate the diagnostic accuracy of C reactive protein in detecting radiologically proved pneumonia and to evaluate how well it can discriminate between bacterial and viral infections of the lower respiratory tract.

DATA SOURCES

Medline and Embase (January 1966 to April 2004), with reference checking.

STUDY SELECTION

We included articles comparing C reactive protein with a chest radiograph or with microbiological work-up as a reference test. Two authors independently assessed methodological items.

RESULTS

None of the studies met all validity criteria. Six studies used an infiltrate on chest radiograph as reference test. Sensitivities ranged from 10% to 98%, specificities from 44% to 99%. For adults, the relation of C reactive protein with an infiltrate (in a subgroup analysis of five studies) showed an area under the curve of 0.80 (95% confidence interval 0.75 to 0.85). In 12 studies, the relation of C reactive protein with a bacterial aetiology of infection of the lower respiratory tract was studied. Sensitivities ranged from 8% to 99%, specificities from 27% to 95%. These data were epidemiologically and statistically heterogeneous, so overall outcomes could not be calculated.

CONCLUSION

Testing for C reactive protein is neither sufficiently sensitive to rule out nor sufficiently specific to rule in an infiltrate on chest radiograph and bacterial aetiology of lower respiratory tract infection. The methodological quality of the diagnostic studies is generally poor. The evidence not consistently and sufficiently supports a wide introduction of C reactive protein as a rapid test to guide antibiotics prescription.

摘要

目的

评估C反应蛋白在检测经放射学证实的肺炎中的诊断准确性,并评估其区分下呼吸道细菌感染和病毒感染的能力。

数据来源

检索1966年1月至2004年4月的Medline和Embase数据库,并进行参考文献核对。

研究选择

纳入将C反应蛋白与胸部X线片或微生物学检查作为参考标准进行比较的文章。两位作者独立评估方法学项目。

结果

所有研究均未完全符合有效性标准。6项研究采用胸部X线片上的浸润影作为参考标准。敏感性范围为10%至98%,特异性范围为44%至99%。对于成年人,C反应蛋白与浸润影的关系(在5项研究的亚组分析中)曲线下面积为0.80(95%置信区间0.75至0.85)。12项研究探讨了C反应蛋白与下呼吸道感染细菌病因的关系。敏感性范围为8%至99%,特异性范围为27%至95%。这些数据在流行病学和统计学上具有异质性,因此无法计算总体结果。

结论

检测C反应蛋白对排除胸部X线片上的浸润影和下呼吸道感染的细菌病因既不够敏感,也不够特异。诊断性研究的方法学质量普遍较差。证据并不一致且充分支持广泛引入C反应蛋白作为指导抗生素处方的快速检测方法。

相似文献

1
Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.
BMJ. 2005 Jul 2;331(7507):26. doi: 10.1136/bmj.38483.478183.EB. Epub 2005 Jun 24.
2
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Thoracic imaging tests for the diagnosis of COVID-19.
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
5
Antibiotics for exacerbations of asthma.
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
9
Screening for aspiration risk associated with dysphagia in acute stroke.
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012679. doi: 10.1002/14651858.CD012679.pub2.
10
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.

引用本文的文献

2
Prognostic value of C-reactive protein levels in pulmonary infections: A systematic review and meta-analysis.
Medicine (Baltimore). 2025 Mar 21;104(12):e41722. doi: 10.1097/MD.0000000000041722.
5
Proteomic profiling of the local and systemic immune response to pediatric respiratory viral infections.
mSystems. 2025 Jan 21;10(1):e0133524. doi: 10.1128/msystems.01335-24. Epub 2024 Nov 29.
6
Pulmonary Is an Inverse Biomarker of Pneumonia in Critically Ill Children and Adults.
Am J Respir Crit Care Med. 2024 Dec 15;210(12):1480-1483. doi: 10.1164/rccm.202403-0516RL.
8
The Diagnostic Value of Human Neutrophilic Peptides 1-3 in Acute Pediatric Febrile Illness.
J Clin Med. 2023 Oct 13;12(20):6514. doi: 10.3390/jcm12206514.
10
Long-term outcomes of lung cancer screening in males and females.
Lung Cancer. 2023 Nov;185:107387. doi: 10.1016/j.lungcan.2023.107387. Epub 2023 Oct 4.

本文引用的文献

6
Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.
Pediatr Infect Dis J. 2003 Nov;22(11):963-8. doi: 10.1097/01.inf.0000095197.72976.4f.
7
C-reactive protein in the diagnosis of community-acquired pneumonia.
Braz J Infect Dis. 2003 Aug;7(4):241-4. doi: 10.1590/s1413-86702003000400003. Epub 2003 Dec 8.
8
Identifying diagnostic accuracy studies in EMBASE.
J Med Libr Assoc. 2003 Jul;91(3):341-6.
10
C-reactive protein levels in community-acquired pneumonia.
Eur Respir J. 2003 Apr;21(4):702-5. doi: 10.1183/09031936.03.00080203.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验